A5043473147- Diabetes Treatment and Management
- Lung Cancer Treatments and Mutations
- Renal Transplantation Outcomes and Treatments
- Hematopoietic Stem Cell Transplantation
- Economic and Financial Impacts of Cancer
- Coronary Interventions and Diagnostics
- Renal and Vascular Pathologies
- Pancreatic function and diabetes
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Polyomavirus and related diseases
- Acute Kidney Injury Research
- Cardiac Arrhythmias and Treatments
- Acute Ischemic Stroke Management
- Heart Failure Treatment and Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Acute Myeloid Leukemia Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Cardiac, Anesthesia and Surgical Outcomes
- Lung Cancer Research Studies
- Metabolism, Diabetes, and Cancer
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Blood Coagulation and Thrombosis Mechanisms
- Pharmacology and Obesity Treatment
- Cardiac pacing and defibrillation studies
United Health Services
2024-2025
Mayo Clinic
2024-2025
Mayo Clinic in Arizona
2024
Yarmouk University
2021
ABSTRACT A 66‐year‐old man with a baseline electrocardiogram (ECG) showing left bundle branch block developed persistent complete atrioventricular following stent placement in the proximal anterior descending artery (LAD), necessitating permanent pacemaker implantation. The complication is believed to have resulted from occlusion of second septal branch, which likely supplied right His system. During elective interventions targeting LAD patients pre‐existing conduction abnormalities, it...
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial dysfunction syndrome observed after allogeneic hematopoietic cell transplant (alloHCT). Our aim was to externally validate the impact of high-risk features on clinical outcomes adult patients meeting updated TA-TMA harmonizing criteria. Between 2005 and 2022, 99 were diagnosed with at Mayo Clinic Rochester (incidence 6.2%) a median 137 days post alloHCT (IQR: 34-283 days). The development associated inferior overall...
Abstract Background While the cardioprotective effects of glucagon-like peptide -1 (GLP-10) agonists are well-documented in diabetic patients, their impact on cardiovascular outcomes patients with obesity without diabetes mellitus remains debated. Purpose This systematic review and meta-analysis randomized controlled trials (RCTs) was conducted to investigate GLP-1 mellitus. Methods A synthesizing RCTs were retrieved by systematically searching PubMed, Web Science, SCOPUS, Cochrane through...
Background: Contrast-induced nephropathy (CIN) is associated with increased mortality and morbidity in patients undergoing coronary angiography (CAG) percutaneous intervention (PCI). We aimed to assess the latest evidence on preventive effects of nitric oxide (NO) donors CIN CAG/PCI. Methods: conducted a systematic review meta-analysis RCTs from PubMed, Web Science, Scopus, Embase, Cochrane searches until May 5th, 2024. Dichotomous data were pooled using risk ratio (RR), continuous mean...
e21104 Background: Crizotinib, alectinib, ceritinib, and brigatinib are approved as second line treatment for ALK+ NSCLC. Crizotinib was the first ALK inhibitor therapy by Food Drug Administration (2011) then ceritinib (2014), alectinib (2015), (2017) were drugs. Following more data, these agents (2017 alectinib; 2020 brigatinib). These remain a option in patients who fail therapy. Cost-effectiveness/utility analyses conducted to assess clinical efficacy with varying costs of agents....
e21102 Background: Crizotinib was approved by the FDA (2011) as first ALK inhibitor for ALK+ NSCLC line drug. This followed approval second treatment of ceritinib (2014), alectinib (2015) and brigatinib (2017); and, following more data, now also therapies in NSCLC. With varying costs clinical benefits progression free survival (PFS), cost effectiveness/utility analyses were conducted. Methods: A 3 state Markov model built including free, death. PFS overall curves digitized exponential...